EMERALD ADVISERS, LLC – United Therapeutics Corporation Transaction History
EMERALD ADVISERS, LLC portfolio value:
$19.52M
portfolio value
EMERALD ADVISERS, LLC quarter portfolio value change:
-11.14%
quarter
United Therapeutics Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -41.75% | -66.84K shares | -18.19M | $209.38 | 93.25K |
| Q2 2022 | share | Decrease | -21.28% | -43.26K shares | 1.23M | $235.64 | 160.09K |
| Q1 2022 | share | Increase | +9.36% | 17.40K shares | -3.69M | $179.41 | 203.35K |
| Q4 2021 | share | Decrease | -2.03% | -3.85K shares | 5.14M | $215.18 | 185.95K |
| Q3 2021 | share | Increase | +1.25% | 2.34K shares | 1.40M | $184.58 | 189.80K |
| Q2 2021 | share | Decrease | -3.63% | -7.06K shares | 1.09M | $179.41 | 187.46K |
| Q1 2021 | share | Decrease | -8.65% | -18.42K shares | 215K | $167.27 | 194.52K |
| Q4 2020 | share | Increase | +10.36% | 19.99K shares | 12.83M | $151.79 | 212.95K |
| Q3 2020 | share | Decrease | -2.62% | -5.19K shares | -4.48M | $101 | 192.96K |
| Q2 2020 | share | Increase | +52.36% | 68.10K shares | 11.64M | $121 | 198.16K |
| Q1 2020 | share | Increase | 0.00% | 130.05K shares | 12.33M | $94.83 | 130.05K |